These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 17164298)
1. The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. Chiappetta G; Ammirante M; Basile A; Rosati A; Festa M; Monaco M; Vuttariello E; Pasquinelli R; Arra C; Zerilli M; Todaro M; Stassi G; Pezzullo L; Gentilella A; Tosco A; Pascale M; Marzullo L; Belisario MA; Turco MC; Leone A J Clin Endocrinol Metab; 2007 Mar; 92(3):1159-63. PubMed ID: 17164298 [TBL] [Abstract][Full Text] [Related]
2. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619 [TBL] [Abstract][Full Text] [Related]
3. BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF protein. Chiappetta G; Basile A; Arra C; Califano D; Pasquinelli R; Barbieri A; De Simone V; Rea D; Giudice A; Pezzullo L; De Laurenzi V; Botti G; Losito S; Conforti D; Turco MC J Clin Endocrinol Metab; 2012 Jan; 97(1):E115-20. PubMed ID: 22072743 [TBL] [Abstract][Full Text] [Related]
4. Regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cells. Zhang HY; Wang HQ; Liu HM; Guan Y; Du ZX Endocr Relat Cancer; 2008 Jun; 15(2):535-44. PubMed ID: 18430896 [TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death. Conticello C; Adamo L; Giuffrida R; Vicari L; Zeuner A; Eramo A; Anastasi G; Memeo L; Giuffrida D; Iannolo G; Gulisano M; De Maria R J Clin Endocrinol Metab; 2007 May; 92(5):1938-42. PubMed ID: 17327374 [TBL] [Abstract][Full Text] [Related]
6. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells. Poulaki V; Mitsiades CS; Kotoula V; Tseleni-Balafouta S; Ashkenazi A; Koutras DA; Mitsiades N Am J Pathol; 2002 Aug; 161(2):643-54. PubMed ID: 12163389 [TBL] [Abstract][Full Text] [Related]
7. BAG3 promoted starvation-induced apoptosis of thyroid cancer cells via attenuation of autophagy. Li S; Zhang HY; Wang T; Meng X; Zong ZH; Kong DH; Wang HQ; Du ZX J Clin Endocrinol Metab; 2014 Nov; 99(11):E2298-307. PubMed ID: 25062457 [TBL] [Abstract][Full Text] [Related]
8. Role of autophagy in the resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis in papillary and anaplastic thyroid cancer cells. Jin SM; Jang HW; Sohn SY; Kim NK; Joung JY; Cho YY; Kim SW; Chung JH Endocrine; 2014 Mar; 45(2):256-62. PubMed ID: 23821365 [TBL] [Abstract][Full Text] [Related]
9. Demethylation of TMS1 gene sensitizes thyroid cancer cells to TRAIL-induced apoptosis. Siraj AK; Hussain AR; Al-Rasheed M; Ahmed M; Bavi P; Alsobhi SA; Al-Nuaim A; Uddin S; Al-Kuraya K J Clin Endocrinol Metab; 2011 Jan; 96(1):E215-24. PubMed ID: 20926535 [TBL] [Abstract][Full Text] [Related]
10. 1-Methoxy-canthin-6-one induces c-Jun NH2-terminal kinase-dependent apoptosis and synergizes with tumor necrosis factor-related apoptosis-inducing ligand activity in human neoplastic cells of hematopoietic or endodermal origin. Ammirante M; Di Giacomo R; De Martino L; Rosati A; Festa M; Gentilella A; Pascale MC; Belisario MA; Leone A; Turco MC; De Feo V Cancer Res; 2006 Apr; 66(8):4385-93. PubMed ID: 16618764 [TBL] [Abstract][Full Text] [Related]
11. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K; Douglas L; Delaney A; Houghton JA Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455 [TBL] [Abstract][Full Text] [Related]
12. Involvement of glyceraldehyde-3-phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells. Du ZX; Wang HQ; Zhang HY; Gao DX Endocrinology; 2007 Sep; 148(9):4352-61. PubMed ID: 17540725 [TBL] [Abstract][Full Text] [Related]
13. BAG3 promotes the phenotypic transformation of primary rat vascular smooth muscle cells via TRAIL. Fu Y; Chang Y; Chen S; Li Y; Chen Y; Sun G; Yu S; Ye N; Li C; Sun Y Int J Mol Med; 2018 May; 41(5):2917-2926. PubMed ID: 29484366 [TBL] [Abstract][Full Text] [Related]
14. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Izeradjene K; Douglas L; Delaney AB; Houghton JA Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213 [TBL] [Abstract][Full Text] [Related]
15. Bag3 promotes resistance to apoptosis through Bcl-2 family members in non-small cell lung cancer. Zhang Y; Wang JH; Lu Q; Wang YJ Oncol Rep; 2012 Jan; 27(1):109-13. PubMed ID: 21971866 [TBL] [Abstract][Full Text] [Related]
16. IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression. Wang SH; Mezosi E; Wolf JM; Cao Z; Utsugi S; Gauger PG; Doherty GM; Baker JR Oncogene; 2004 Jan; 23(4):928-35. PubMed ID: 14647456 [TBL] [Abstract][Full Text] [Related]
17. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919 [TBL] [Abstract][Full Text] [Related]
18. Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression. Wang W; Zhao J; Wang H; Sun Y; Peng Z; Zhou G; Fan L; Wang X; Yang S; Wang R; Fang D Exp Cell Res; 2010 Sep; 316(15):2456-64. PubMed ID: 20595005 [TBL] [Abstract][Full Text] [Related]
19. Valproic acid sensitizes TRAIL-resistant anaplastic thyroid carcinoma cells to apoptotic cell death. Cha HY; Lee BS; Kang S; Shin YS; Chang JW; Sung ES; Kim YS; Choi JW; Kim JH; Kim CH Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S716-24. PubMed ID: 23982257 [TBL] [Abstract][Full Text] [Related]
20. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]